Compare KOD & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KOD | THFF |
|---|---|---|
| Founded | 2009 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 795.5M | 686.6M |
| IPO Year | 2018 | N/A |
| Metric | KOD | THFF |
|---|---|---|
| Price | $24.09 | $64.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $22.67 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 720.6K | 52.3K |
| Earning Date | 11-13-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 3.18% |
| EPS Growth | N/A | ★ 69.68 |
| EPS | N/A | ★ 6.25 |
| Revenue | N/A | ★ $250,755,000.00 |
| Revenue This Year | N/A | $33.24 |
| Revenue Next Year | N/A | $8.15 |
| P/E Ratio | ★ N/A | $10.26 |
| Revenue Growth | N/A | ★ 31.89 |
| 52 Week Low | $1.92 | $42.05 |
| 52 Week High | $26.21 | $65.00 |
| Indicator | KOD | THFF |
|---|---|---|
| Relative Strength Index (RSI) | 60.32 | 74.46 |
| Support Level | $21.24 | $63.36 |
| Resistance Level | $24.97 | $65.00 |
| Average True Range (ATR) | 1.70 | 1.12 |
| MACD | -0.16 | 0.46 |
| Stochastic Oscillator | 62.58 | 89.35 |
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.